Retraction: Impaired potentiation of theta oscillations during a visual cortical plasticity paradigm in individuals with schizophrenia - Scorecard - MDSpire

Retraction: Impaired potentiation of theta oscillations during a visual cortical plasticity paradigm in individuals with schizophrenia

  • May 6, 2026

  • 0 min

Share

Clinical Scorecard: Withdrawal of Study: Deficient Enhancement of Theta Oscillations in a Visual Cortical Plasticity Framework Among Schizophrenia Patients

At a Glance

CategoryDetail
ConditionSchizophrenia
Key MechanismsTheta oscillations and visual cortical plasticity
Target PopulationIndividuals with schizophrenia
Care SettingResearch and clinical settings

Key Highlights

  • Retraction of a study due to data file errors affecting participant data
  • Investigation confirmed the inability to recover original data files
  • Authors are revising the paper using an intact subgroup of patients

Guideline-Based Recommendations

Diagnosis

  • Review EEG data for accuracy in schizophrenia studies

Management

  • Consider intact subgroups for future research

Monitoring & Follow-up

  • Ensure data integrity in clinical research

Risks

  • Potential misinterpretation of findings due to data errors

Patient & Prescribing Data

Individuals diagnosed with schizophrenia

Focus on accurate data collection and analysis

Clinical Best Practices

  • Conduct thorough data verification before publication
  • Implement robust data management protocols in research
  • Engage in transparent communication regarding study limitations

Related Resources & Content

Original Source(s)

Retraction: Impaired potentiation of theta oscillations during a visual cortical plasticity paradigm in individuals with schizophrenia

  • May 6, 2026

Related Content

Gender-Diverse Youths Reported More Psychotic-Like Experiences

Longitudinal cohort data linked bullying and persistently unsupportive state gender-identity policies with worsening psychotic-like experiences among gender-diverse youths.

FDA Updates Lumateperone Label With Relapse-Prevention Data

Label update incorporates randomized withdrawal trial findings showing delayed time to relapse and consistent safety profile in schizophrenia

Romanian male patients with the dual diagnosis of schizophrenia and alcohol use disorder: a prospective study of clinical, social, and treatment-related factors affecting quality of life